Banque Cantonale Vaudoise’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.88M | Sell |
7,091
-1,030
| -13% | -$418K | 0.12% | 177 |
|
2025
Q1 | $4.04M | Buy |
+8,121
| New | +$4.04M | 0.18% | 114 |
|
2024
Q3 | $5.94M | Sell |
9,597
-446
| -4% | -$276K | 0.24% | 89 |
|
2024
Q2 | $5.55M | Sell |
10,043
-1,915
| -16% | -$1.06M | 0.22% | 78 |
|
2024
Q1 | $6.95M | Sell |
11,958
-1,893
| -14% | -$1.1M | 0.27% | 69 |
|
2023
Q4 | $7.35M | Sell |
13,851
-3,683
| -21% | -$1.95M | 0.32% | 57 |
|
2023
Q3 | $8.87M | Buy |
17,534
+44
| +0.3% | +$22.3K | 0.44% | 38 |
|
2023
Q2 | $9.12M | Buy |
17,490
+482
| +3% | +$251K | 0.43% | 40 |
|
2023
Q1 | $9.8M | Sell |
17,008
-204
| -1% | -$118K | 0.48% | 37 |
|
2022
Q4 | $9.48M | Sell |
17,212
-141
| -0.8% | -$77.7K | 0.5% | 34 |
|
2022
Q3 | $8.8M | Sell |
17,353
-1,611
| -8% | -$817K | 0.5% | 33 |
|
2022
Q2 | $10.3M | Buy |
18,964
+208
| +1% | +$113K | 0.53% | 30 |
|
2022
Q1 | $11.1M | Sell |
18,756
-1,099
| -6% | -$649K | 0.48% | 33 |
|
2021
Q4 | $13.2M | Sell |
19,855
-638
| -3% | -$426K | 0.52% | 29 |
|
2021
Q3 | $11.7M | Buy |
20,493
+4,714
| +30% | +$2.69M | 0.5% | 30 |
|
2021
Q2 | $7.96M | Sell |
15,779
-2,429
| -13% | -$1.23M | 0.35% | 49 |
|
2021
Q1 | $8.31M | Buy |
18,208
+1,723
| +10% | +$786K | 0.42% | 40 |
|
2020
Q4 | $7.68M | Buy |
16,485
+2,567
| +18% | +$1.2M | 0.43% | 45 |
|
2020
Q3 | $6.15M | Sell |
13,918
-1,545
| -10% | -$682K | 0.39% | 51 |
|
2020
Q2 | $5.6M | Buy |
15,463
+2,502
| +19% | +$907K | 0.41% | 49 |
|
2020
Q1 | $3.68M | Sell |
12,961
-2,108
| -14% | -$598K | 0.31% | 60 |
|
2019
Q4 | $4.9M | Buy |
+15,069
| New | +$4.9M | 0.34% | 54 |
|